Document Detail

Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.
MedLine Citation:
PMID:  20232589     Owner:  NLM     Status:  MEDLINE    
Scleromyxedema is a chronic, idiopathic disorder characterized by cutaneous dermal mucin deposition in association with increased dermal collagen and absence of thyroid disease. The clinical features involve sclerosis of skin with numerous, 2-3 mm, firm, waxy, papules in a symmetrical distribution pattern. The skin lesions may progress to widespread and indurated plaques resulting in patient disability via decreased mobility, sclerodactyly and microstomia. Abnormalities in the muscular, neurologic, rheumatologic, pulmonary, renal and cardiovascular systems may accompany the cutaneous lesions. Multiple attempts at therapeutic interventions have failed due to inconsistent, unsatisfactory results and/or severe adverse effects. Herein, the authors describe a case of scleromyxedema successfully treated with high-dose intravenous immunoglobulin (hdIVIG).
Novie Sroa; Shannon Campbell; Mark Bechtel
Related Documents :
19382999 - Rituximab-induced vasculitis: a case report and review of the medical published work.
19684509 - Desmoplastic nevus: clinicopathologic keynotes.
2768579 - Acral persistent papular mucinosis.
15074349 - Cutaneous linear atrophy following intralesional corticosteroid injection in the treatm...
7971559 - Agminated lentiginosis: case report and review of the literature.
10727319 - Cutaneous schistosomiasis: report of a case and review of the literature.
20849459 - Recurrent erythema multiforme triggered by progesterone sensitivity.
9018419 - Gerodermia osteodysplastica in a bedouin sibship: further delineation of the syndrome.
14586609 - Propofol in status epilepticus: little evidence, many dangers?
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  9     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-17     Completed Date:  2010-04-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  263-5     Citation Subset:  IM    
Division of Dermatology, Ohio State University Medical Center, Columbus, OH 43221, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Immunoglobulins, Intravenous / therapeutic use*
Scleromyxedema / drug therapy*
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Porokeratosis in a patient with hepatitis of unclear etiology.
Next Document:  Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding.